HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$9.85
Day range
$6.46 - $8.75
Year range
$6.46 - $20.70
Market cap
337.05M USD
Avg Volume
678.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 20.25M | 7.84% |
Operating expense | 54.84M | 28.15% |
Net income | -43.84M | -35.80% |
Net profit margin | -216.47 | -25.92% |
Earnings per share | -0.92 | 5.15% |
EBITDA | -36.84M | -43.82% |
Effective tax rate | -0.90% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 195.89M | 19.41% |
Total assets | 247.62M | 23.45% |
Total liabilities | 294.08M | 22.17% |
Total equity | -46.46M | — |
Shares outstanding | 46.11M | — |
Price to book | -9.75 | — |
Return on assets | -34.61% | — |
Return on capital | -94.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -43.84M | -35.80% |
Cash from operations | -42.02M | -32.42% |
Cash from investing | -25.96M | -292.06% |
Cash from financing | 34.00K | -99.94% |
Net change in cash | -67.95M | -286.48% |
Free cash flow | -27.76M | -39.94% |
About
Founded
2004
Headquarters
Website
Employees
234
